Method and medicament for inhibiting the expression of a defined gene
Details for Australian Patent Application No. 2008202208 (hide)
International Classifications
Event Publications
5 June 2008 Application Open to Public Inspection
Published as AU-B-2008202208
5 June 2008 Complete Application Filed
29 October 2009 Application Accepted
Published as AU-B-2008202208
11 February 2010 Opposition Lodged
Sirna Therapeutics, Inc. has lodged an opposition against Alnylam Europe AG.
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008202207-Method for demonstrating differences in antioxidant functionality among cosmetic products
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser